These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23196655)

  • 1. Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate.
    Dong Q; Fu XX; Du LL; Zhao N; Xia CK; Yu KW; Cheng LX; Du YM
    Biol Pharm Bull; 2013; 36(2):268-75. PubMed ID: 23196655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
    Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
    Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
    Zhang P; Xing J; Luo A; Feng J; Liu Z; Gao C; Ma J
    J Pharm Pharmacol; 2013 Sep; 65(9):1321-8. PubMed ID: 23927470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
    Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
    Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA
    Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
    Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
    Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
    Kiesecker C; Alter M; Kathöfer S; Zitron E; Scholz EP; Thomas D; Kreuzer J; Katus HA; Bauer A; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):212-20. PubMed ID: 16736158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block effect of capsaicin on hERG potassium currents is enhanced by S6 mutation at Y652.
    Xing J; Ma J; Zhang P; Fan X
    Eur J Pharmacol; 2010 Mar; 630(1-3):1-9. PubMed ID: 19903464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protriptyline block of the human ether-à-go-go-related gene (HERG) K+ channel.
    Jo SH; Hong HK; Chong SH; Choe H
    Life Sci; 2008 Jan; 82(5-6):331-40. PubMed ID: 18191158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel.
    Jo SH; Hong HK; Chong SH; Lee HS; Choe H
    Pharmacol Res; 2009 Nov; 60(5):429-37. PubMed ID: 19497368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.
    Scherer D; von Löwenstern K; Zitron E; Scholz EP; Bloehs R; Kathöfer S; Thomas D; Bauer A; Katus HA; Karle CA; Kiesecker C
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):73-83. PubMed ID: 18458880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
    Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
    Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
    Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA
    Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of azelastine on cardiac repolarization of guinea-pig cardiomyocytes, hERG K⁺ channel, and human L-type and T-type Ca²⁺ channel.
    Park MH; Lee SH; Chu DH; Won KH; Choi BH; Choe H; Jo SH
    J Pharmacol Sci; 2013 Sep; 123(1):67-77. PubMed ID: 24005046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
    Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652.
    Jo SH; Hong HK; Chong SH; Won KH; Jung SJ; Choe H
    Eur J Pharmacol; 2008 Sep; 592(1-3):19-25. PubMed ID: 18634780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.
    Duan JJ; Ma JH; Zhang PH; Wang XP; Zou AR; Tu DN
    Acta Pharmacol Sin; 2007 Jul; 28(7):959-67. PubMed ID: 17588331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.